Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
- Status
- COMPLETED
- Phase
- PHASE2
3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA
- Status
- WITHDRAWN
- Phase
- PHASE1
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
- Status
- COMPLETED
- Phase
- PHASE1
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epigenetic Reprogramming in Relapse AML
- Status
- TERMINATED
- Phase
- PHASE1
Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A
- Status
- COMPLETED
- Phase
- PHASE3
Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
- Status
- COMPLETED
- Phase
- PHASE1
Peginterferon and TIL Therapy for Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Investigator Initiated Phase 1 Study of TBI-1301
- Status
- UNKNOWN
- Phase
- PHASE1
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
- Status
- TERMINATED
- Phase
- PHASE2
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1